Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AST SpaceMobile Inc (ASTS) vs Cassava Sciences Inc (FLNA) Price & Performance

AST SpaceMobile IncTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

AST SpaceMobile Inc vs Cassava Sciences Inc — how do they compare? AST SpaceMobile Inc trades at $71.64 (market cap $20.54B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: AST SpaceMobile Inc is far larger — about 430.2× Cassava Sciences Inc's market cap, and AST SpaceMobile Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

ASTSFLNA
Market Cap
$20.54B$47.75M
Sector
MediaHealth
52-Week High
$133.09$4.64
52-Week Low
$36.91$0.87
Enterprise Value
$21.25B-$34.93M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AST SpaceMobile Inc

AST SpaceMobile (ASTS) trades at $71.94, up 6.8% on the day, reflecting strong momentum despite recent earnings misses. The stock shows a bullish technical signal with key resistance at $73 and support at $69. Fundamentally, revenue grew to $71M in 2025, but net losses persist at -$342M, with a negative net margin of -482.17%. The company maintains a $1.3B backlog and raised its 2026 revenue guidance to $150M-$200M, indicating growth potential amid high cash burn.

Outlook: ASTS offers speculative upside driven by satellite network expansion and partnerships, with a consensus price target of $85.45 (19% upside). Risks include sustained losses, execution delays, and high valuation (P/S of 230.94). Investors should weigh growth prospects against financial sustainability concerns.

Cassava Sciences Inc

FLNA trades at $0.995, up 3.75% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of -$0.18 beating expectations of -$0.225. Financials show negative cash flows and profitability, with ROE at -55.79% and net income of -$90.97M in 2025. Analyst consensus is strongly positive with 8 buy ratings out of 12.

Despite operational losses, FLNA's consistent earnings beats and strong analyst support suggest potential upside if clinical developments progress. Key risks include sustained cash burn, lack of revenue, and dependence on successful drug trials for Tuberous Sclerosis Complex. The stock remains speculative with high volatility expected.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AST SpaceMobile Inc

AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building the global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio. AST is on a mission to eliminate the connectivity gaps faced by mobile subscribers and finally bring broadband to the billions who remain unconnected.

Read more on ASTS

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA